Buccal patch: A technical note

International Journal of Pharmaceutical Sciences Review and Research

Volumn 4, Issue 3, 2010, Pages 178-182

  Parmar, Harshad G ^a   Jain, Janak J ^a   Patel, Tarun K ^a   Patel, Vishnu M ^a  

^a APMC College of Pharmaceutical Education and Research   (India)

Author keywords

Buccal mucosa; Drug delivery; Permeation; Transmucosal

Indexed keywords

ASPARTAME; CLOVE OIL; DRUG; ETHYL CELLULOSE; HYDROXYETHYLCELLULOSE; HYDROXYPROPYLCELLULOSE; LACTOSE; MACROGOL; MANNITOL; MENTHOL; POLYVINYL ALCOHOL; POVIDONE; SUCRALOSE; VANILLIN;

BUCCAL PATCH; CONTROLLED DRUG RELEASE; DRUG ABSORPTION; DRUG DESIGN; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG PENETRATION; DRUG STABILITY; MOUTH CAVITY; MOUTH MUCOSA; REVIEW;

EID: 79952027257     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. L.M. Sanders, Drug delivery system and routes of administration of peptide and protein drugs, Eur. J. Drug Metab. Pharmacokinet. 15 (1990) 95-102.
2. Y.J. Wang, R. Pearlman, Stability and characterization of protein and peptide drugs, case histories, in Pharmaceutical Technology, New York/London, vol. 5.
3. H.H. Alur, T.P. Johnston, A.K. Mitra, Encyclopedia of Pharmaceutical Technology, in: J. Superbrick, J.C. Boylan (Eds.), Peptides and Proteins: Buccal Absorption, vol. 20 (3), Marcel Dekker Inc., New York, 2001, 193-218.
4. Wikipedia, The free encyclopedia, http://en.wikipedia.org/wiki/.
5. M.M.Veillard et al., "Preliminary Studies of Oral Mucosal Delivery of Peptide Drugs," J. Controlled Release 6, (1987), 123-131.
6. Y. Kurosaki et al., "Effects of Surfactants on the Absorption of Salicylic Acid from Hamster Cheek Pouch as a Model of Keratinized Oral Mucosa," Int. J. Pharm. 47, (1988), 13-19.
7. A.J. Hoogstraate et al., "Diffusion Rates and Transport Pathways of FITC-Labelled Model Compounds through Buccal Epithelium," Proc. Int. Symp. Contr. Rel. Bioact.Mater. 20, (1993),234-235.
8. A.J. Hoogstraate et al. "Diffusion Rates and Transport Pathways of FITC-Labelled Model Compounds through Buccal Epithelium,"Pharm. Res. 9, (1992), S-188.
9. C.A. Squier et al., "Lipid Content and Water Permeability of Skin and Oral Mucosa," J. Invest. Dermatol. 96 (1), (1991),123-126.
10. P. Collins et al., Comparative Study of Porcine Oral Epithelium. J.Dent. Res. 60(A), (1981), 543.
11. A.H. Shojaei and X. Li, "In Vitro Permeation of Acyclovir through Porcine Buccal Mucosa," Proc. Int. Symp. Contr. Rel. Bioact. Mater. (Vol. 23) (Controlled Release Society, 1996), 507-508.
12. A.H. Shojaei and X. Li, "Determination of Transport Route of Acyclovir across Buccal Mucosa," in Proc. Int. Symp. Contr. Rel. Bioact. Mater. (Vol. 24) (Controlled Release Society, 1997), 427-428.
13. A.M. Manganaro and P.W.Wertz, The Effects of Permeabilizers on the In Vitro Penetration of Propranolol through Porcine Buccal Epithelium. Mil.Med. 161 (11), (1996),669-672.
14. R. Gandhi and J. Robinson, "Mechanisms of Penetration Enhancement for TransBuccal Delivery of Salicylic Acid," Int. J. Pharm. 85, (1992),129-140.
15. G.J.M.Wolany et al., "Buccal Absorption of Sandostatin (octreotide) in Conscious Beagle Dogs," Proc. Int. Symp. Contr. Rel. Bioact. Mat. 17, (1990), 224-225.
16. S. Nakane et al., "Oramucosal Delivery of LHRH: Pharmacokinetic Studies of Controlled and Enhanced Transmucosal Permeation," Pharm. Dev. Technol. 20 (3), (1996), 251-259.
17. A. Steward et al., "The Effect of Enhancers on the Buccal Absorption of Hybrid (BDBB) Alpha-Interferon," Int. J. Pharm. 104, (1994),145-149.
18. S. Senel et al.,"Enhancement of In Vitro Permeability of Porcine Buccal Mucosa by Bile Salts: Kinetic and Histological Studies," J. Contr. Rel. 32, (1994),45-56.
19. B.J. Aungst and N.J. Rogers, "Site Dependence of Absorption-Promoting Actions of Laureth-9,Na Salicylate,Na2EDTA, and Aprotinin on Rectal,Nasal, and Buccal Insulin Delivery," Pharm. Res. 5 (5), (1988),305-308.
20. J. Zhang et al., "An In Vivo Dog Model for Studying Recovery Kinetics of the Buccal Mucosa Permeation Barrier after Exposure to Permeation Enhancers: Apparent Evidence of Effective Enhancement without Tissue Damage," Int. J. Pharm. 101, (1994), 15-22.
21. B.J. Aungst, "Site Dependence and Structure-Effect Relationships for Alkylglycosides as TransMucosal Absorption Promoters for Insulin," Int. J. Pharm. 105, (1994),219-225.
22. N.A. Peppas and P.A. Buri, "Surface, Interfacial and Molecular Aspects of Polymer Bioadhesion on Soft Tissues," J. Contr. Rel. 2, (1985),257-275.
23. H.S. Ch'ng et al., "Bioadhesive Polymers as Platforms for Oral Controlled Drug Delivery II: Synthesis and Evaluation of Some Swelling, Water-Insoluble Bioadhesive Polymers," J. Pharm. Sci. 74 (4), (1985), 399-405.
24. R.E. Gandhi and J.R. Robinson, "Bioadhesion in Drug Delivery," Indian J. Pharm. Sci. 50 (May/June), (1988),145-152.
25. S.S. Leung and J.R. Robinson,"Polymer Structure Features Contributing to Mucoadhesion: II," J. Contr. Rel. 12, (1990),187-194
26. Y.D. Sanzgiri et al., "Evaluation of Mucoadhesive Properties of Hyaluronic Acid Benzyl Esters," Int. J. Pharm. 107, (1994),.91-97.
27. K. Park and J.R. Robinson, "Bioadhesive Polymers as Platforms for Oral Controlled Drug Delivery: Method to Study Bioadhesion," Int. J. Pharm. 19, (1984),107-127.
28. T.Nagai and Y.Machida,"Buccal Delivery Systems Using Hydrogels," Adv. Drug Del. Rev. 11, (1993),179-191.
29. S.Anlar et al., "Formulation and In Vitro-In Vivo Evaluation of Buccoadhesive Morphine Sulfate Tablets," Pharm. Res. 11 (2), (1994),231-236.
30. R. Anders and H. Merkle, "Evaluation of Laminated Mucoadhesive Patches for Buccal Drug Delivery," Int. J. Pharm. 49, (1989),231-240.
31. J.-H. Guo, "Investigating the Surface Properties and Bioadhesion of Buccal Patches," J. Pharm. Pharmacol. 46, (1994),647-650.
32. R.Anders et al.,"Buccal Absorption of Protirelin: An Effective Way to Stimulate Thyrotropin and Prolactin," J. Pharm. Sci. 72, (1983),1481-1483.
33. C.M. Lehr et al., "In Vitro Evaluation of Mucoadhesive Properties of Chitosan and Some Other Natural Polymers," Int. J. Pharm. 78, (1992),43-48.